2025年新药审评年度报告(英)
聚焦2025年新药审评年度报告(英)。The report highlights the year’s 46 novel drug approvals. They are considered novel because they have not previously been approved or marketed in the U.S.
报告摘要
聚焦2025年新药审评年度报告(英)。The report highlights the year’s 46 novel drug approvals. They are considered novel because they have not previously been approved or marketed in the U.S.
核心要点
- 内容概览：核心主题与资料背景
- 主要内容与关键观点
- 相关议题与阅读参考
报告信息
- 文件全名
- 《2025年新药审评年度报告（英）-36页.pdf》
- 核心议题
常见问题
《2025年新药审评年度报告(英)》主要包含哪些内容?
聚焦2025年新药审评年度报告(英)。The report highlights the year’s 46 novel drug approvals. They are considered novel because they have not previously been approved or marketed in the U.S.
这份报告覆盖哪一年、篇幅多大?
覆盖 2026 年,全文共 36 页。
这份报告是免费的吗?如何获取?
本报告为付费报告,可在资料宝站内下单后获取完整内容。
报告涉及哪些关键议题?
重点分析了2025年新药审评年度报告等议题。
继续阅读
查看全部 →